In a report published Friday, Jefferies reiterated its Buy rating on Cabot Corp. CBT, but lowered its price target from $47.00 to $44.00.
Jefferies noted, “With Cabot confirming a slow start to Q2 (widely expected, in our view), we believe the shares will likely be range-bound until we have a clearer view of the demand recovery. We are trimming 2013E and 2014E each by $0.20, and lowering our 12-month PT $3 to $44, but with Cabot operating in trough-like conditions and high incremental margins on a recovery, we reiterate our Buy rating.”
Cabot Corp. closed on Thursday at $37.29.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in